Table 1.
Multiplier equation | Study period | ||||||
---|---|---|---|---|---|---|---|
2007–2008 | 2012–2014 | ||||||
Q fever IFA sensitivity multiplier | 1/sensitivity | 1/1 | 1 | 1/1 | 1 | ||
Q fever IFA specificity multiplier | Specificity | 0.95 | 0.95 | 0.95 | 0.95 | ||
SFGR IFA sensitivity multiplier | 1/sensitivity | 1/0.94 | 1.06 | 1/0.94 | 1.06 | ||
SFGR IFA specificity multiplier | Specificity | 1 | 1 | 1 | 1 | ||
KCMC multiplier | No. of households interviewed/no. households seeking care at KCMC for fever ≥ 3 days | ||||||
Age 0–4 years | 198/17 | 11.65 | 198/17 | 11.63 | |||
Age 5–14 years | 361/10 | 361/10 | 361/10 | 36.10 | |||
Age ≥ 15 years | 810/35 | 23.14 | 810/35 | 23.14 | |||
MRRH multiplier | No. of households interviewed/no. households seeking care at MRRH for fever ≥ 3 days | ||||||
Age 0–4 years | 198/67 | 2.96 | 198/67 | 2.96 | |||
Age 5–14 years | 361/137 | 2.64 | 361/137 | 2.64 | |||
Age ≥ 15 years | 810/299 | 2.71 | 810/299 | 2.71 | |||
Paired sera multiplier | No. of patients included in the study/no. of patients included in the study with paired sera | Q fever | SFGR | Q fever | SFGR | ||
Age 0–4 years | 256/143 | 256/124 | 1.79 | 2.06 | 430/177 | 2.43 | |
Age 5–14 years | 59/45 | 59/42 | 1.31 | 1.40 | 111/87 | 1.28 | |
Age ≥ 15 years | 274/156 | 274/141 | 1.76 | 1.94 | 573/377 | 1.52 | |
Time multiplier | No. of days in a week/no. of enrollment days per week | 7/5 | 1.40 | 7/5 | 1.40 | ||
Enrollment multiplier | No. of eligible patients/no. of patients enrolled in fever surveillance | 1,310/870 | 1.51 | 2,962/1,414 | 2.09 | ||
Study duration adjustment | No. days per year/study duration (in days) | 365/349 | 1.05 | 365/828 | 0.44 |
IFA = indirect immunofluorescence assay; KCMC = Kilimanjaro Christian Medical Centre; MRRH = Mawenzi Regional Referral Hospital; SFGR = spotted fever group rickettsioses.